While researchers have already linked the cholesterol drug Lipitor (atorvastatin) with a higher risk of type 2 diabetes, a new study "strengthens evidence of a connection," according to a Reuters report. However, this strong risk comes with other factors that, to some extent, patients could do something about--including excess weight, high blood sugar, elevated triglycerides and high blood pressure. These factors are "very good at distinguishing people at high or low risk for developing new-onset diabetes with atorvastatin," lead researcher Dr. David D. Waters, of the University of California at San Francisco, told Reuters Health. Article